The Department of Neurology Division of Movement Disorders, in partnership with the Department of Neurological Surgery, maintains a Neurology/Neurosurgery Center of Excellence in Neuromodulation offering a wide range of state-of-the-art invasive and noninvasive therapeutic interventions that target the central nervous system in both adults and children with movement disorders. Every year, we see a significant number of patients with disabling movement disorders who do not respond or no longer respond to pharmacological therapies. For such patients, particularly those with Parkinson’s disease, neuromodulation has become a therapeutic mainstay.
The field of neuromodulation continues to rapidly advance, with the development of new technologies and the identification of targets in the brain to improve the quality of life of patients with a growing number of movement disorder diagnoses. In this session, we will discuss recent advances in our understanding of these diseases and how this knowledge has led to new neuromodulation treatments targeting specific areas of the brain. We will also highlight ongoing research in neuromodulation for conditions such as cerebral palsy.
Richard P. Mayeux, MD, MSc & E. Sander Connolly Jr., MD, FACS
What Neuromodulation Offers to Patients with Parkinson’s Disease and Other Movement Disorders Such as Essential Tremor
Blair Ford, MD
Invasive and Non-Invasive Neuromodulation Approaches for Movement Disorders
Guy M. McKhann, MD, PhD
Harnessing Cerebellar Rhythm with Neuromodulation for Ataxia and Tremor
Sheng-Han Kuo, MD
New Movement Disorders Therapy for Cerebral Palsy
Jason B. Carmel, MD, PhD & Linn Katus, DO, MSc
Panel Discussion and Q&A
Moderators: Richard P. Mayeux, MD, MSc & E. Sander Connolly Jr., MD, FACS
This activity has been approved for AMA PRA Category 1 Credit™